HCA
HCA Holdings Inc
NYSE: HCA · HEALTHCARE · MEDICAL CARE FACILITIES
$434.78
+0.66% today
Updated 2026-04-29
Market cap
$96.68B
P/E ratio
14.90
P/S ratio
1.27x
EPS (TTM)
$29.02
Dividend yield
0.62%
52W range
$328 – $556
Volume
1.1M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
5.3
Growth
C+6.0
Quality
B8.0
Profitability
A6.0
Valuation
B5/9
Piotroski F-Score
Moderate
1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$535.00
+23.05%
12-Month target
$487.91
+12.22%
Intrinsic (DCF)
$502.29
Margin of safety
-5.81%
2 Strong Buy13 Buy9 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 136.30% — strong efficiency
+ Free cash flow $895.00M — positive
+ Debt/equity -8.33x — low leverage
Risks
- Altman Z 1.71 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $60.23B | $64.97B | $70.60B | $75.60B | $76.39B | $79.4B |
| Net income | $5.64B | $5.24B | $5.76B | $6.78B | $1.62B | — |
| EPS | — | — | — | — | $29.02 | $30.53 |
| Free cash flow | $4.13B | $4.69B | $5.64B | $7.69B | $895.00M | — |
| Profit margin | 9.37% | 8.07% | 8.16% | 8.97% | 8.89% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-02-18 | MCALEVEY, MICHAEL R | Sale | 1,694 | $533.37 |
| 2026-02-13 | MCALEVEY, MICHAEL R | Sale | 5,000 | — |
| 2026-02-13 | MCALEVEY, MICHAEL R | Buy | 5,000 | $236.61 |
Peer comparison
Smart narrative
HCA Holdings Inc trades at $434.78. representing a P/E of 14.90x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.71, it sits in the distress. TTM revenue stands at $76.39B. with profit margins at 8.89%. Our DCF model estimates intrinsic value at $502.29.
Frequently asked questions
What is HCA Holdings Inc's stock price?
HCA Holdings Inc (HCA) trades at $434.78.
Is HCA Holdings Inc overvalued?
Smart Value Score 63/100 (Grade C+, Hold). DCF value $502.29.
What is the price target of HCA Holdings Inc (HCA)?
The analyst target price is $535.00, representing +23.1% upside from the current price of $434.78.
What is the intrinsic value of HCA Holdings Inc (HCA)?
Based on our DCF model, intrinsic value is $502.29, a -5.8% margin of safety versus $434.78.
What is the future stock price of HCA by 2030?
Our research-backed model estimates HCA Holdings Inc could reach $5,143.06 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is HCA Holdings Inc's revenue?
TTM revenue is $76.39B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.71 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.27x
ROE136.30%
Beta1.37
50D MA$506.72
200D MA$455.80
Shares out0.22B
Float0.15B
Short ratio—
Avg volume1.1M
Performance
1 week+0.54%
1 month-8.42%
3 months-10.96%
YTD-6.87%
1 year—
3 years—
5 years—